Rock Creek Pharmaceuticals to Present at the 17th Annual Rodman & Renshaw Global Investment Conference
SARASOTA, Fla., Aug. 14, 2015 /PRNewswire/ -- Rock Creek Pharmaceuticals, Inc., (NASDAQ: RCPI), a clinical stage, drug development company which has focused on the application of its lead compound to chronic inflammatory conditions, announced that the Company will be featured as a presenting company at the 17th Annual Rodman & Renshaw Global Investment Conference, sponsored by H.C. Wainwright & Co., LLC. The conference is being held September 8-10, 2015, at The St. Regis Hotel in New York City.
If you have something to sell you've got to see to it that people know about it.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.